An improved understanding of individual risk would account for ethnicity, advancing age, family history of prostate cancer, and genetics (eg, mutations in BRCA1, BRCA2, ATM, and the mismatch repair genes). This evidence concerns the gene BRCA2 and prostate carcinoma.